U.S.
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Amendment
No. 1
CURRENT
REPORT PURSUANT TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): December 18, 2009
Nutra
Pharma Corp.
(Exact
name of registrant as specified in its charter)
|
California
|
000-32141
|
91-2021600
|
|
(State
or jurisdiction of
|
(Commission
|
(I.R.S.
Employer
|
|
incorporation
or organization)
|
File
Number)
|
Identification
No.)
|
1537 NW
65th
Avenue
Plantation,
FL 33313
(Address
of principal executive offices) (Zip Code)
Registrant's
telephone number: 954 509-0911
(Former
name or former address, if changed since last report)
Item 4.01
Changes in Registrant’s Certifying Accountant
On
December 24, 2009, Nutra Pharma Corp. (the “Registrant”) filed a Form 8-K
reporting that on December 18, 2009, the Registrant changed accountants from
Stark Winter Schenkein & Co., LLP. (“SWS”) to Kingery and Crouse P. A.
(“KCPA”). The purpose of amendment number 1 to this Form 8-K is to
correct the inadvertent error in the December 24, 2009 Form 8-K filing regarding
the statement in Item 4.01, Section (a) (1) (i), that the SWS engagement
partner, Neil Winter, became associated with KCPA on December 18, 2009, when in
fact he will become associated as a partner with KCPA on January 1,
2010.
SIGNATURES
Pursuant
to the requirements of the Securities and Exchange Act of 1934, the Registrant
has duly caused this Current Report on Form 8-K to be signed on its behalf by
the undersigned hereunto duly authorized.
Nutra
Pharma Corp.
DATED:
December 31, 2009
|
|
/s/
|
Rik
Deitsch
|
|
|
|
|
Rik
Deitsch, President, Chief Executive
Officer
|